This image has an empty alt attribute; its file name is Immagine-WhatsApp-2023-12-04-ore-10.44.45_6c76537b-1024x695.jpg

The NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka (Zambia). NeuroSolve is a four-year project funded by EDCTP3, lead by an African-European research consortium involves the University of Dar es Salaam (UDSM – Tanzania), Sokoine University of Agriculture (SUA – Tanzania), University of Zambia (UNZA – Zambia), Revolution Worldwide Srl – Impresa Sociale (R-EvoWW – Italy) and Universiteit Ghent (UGent – Belgium).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

HIV-associated multimorbidity: a trial of a “screen and link” strategy post hospital admission to improve outcomes in adults in sub-Saharan Africa

Our organisation has submitted a project proposal titled MULTILINK-HIV under the European funding call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage: Global collaboration action towards better prevention, treatment and clinical management of HIV coinfections or co-morbidities

R-Evolution Worldwide as part of a multidisciplinary team of African and European researchers developed the VectorEnd project.

The increasing urbanization in Africa, paralleled by inadequate environmental sanitation, significantly contributes to the proliferation of Aedes mosquitoes, which transmit many arboviruses, including dengue virus (DENV) and Chikungunya virus (CHIKV). In 

IMPROVE-HIV proposal submitted to EDCTP3 to address HIV, HBV and schistosomiasis co-infections in sub-Saharan Africa

R-Evolution WorldWide, has recently submitted the project proposal IMPROVE-HIV under the European & Developing Countries Clinical Trials Partnership (EDCTP) call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage – Global collaboration action towards better prevention, treatment and clinical management